复发性流产男方精子印记基因DNA甲基化异常
该病例对照研究纳入112对不明原因复发性流产(RPL)夫妇和106对健康生育夫妇,采用焦磷酸测序检测男方精子印记基因甲基化及整体5mC水平。发现RPL组精子整体5mC降低、LINE1启动子三个CpG位点甲基化降低,IGF2-H19 DMR和IG-DMR特定CpG位点甲基化降低,而MEST、ZAC、KvDMR、PEG3和PEG10甲基化升高,提示男方精子表观遗传异常与RPL相关。
要点
- RPL男方精子整体5mC水平及LINE1启动子甲基化显著降低。
- IGF2-H19 DMR和IG-DMR特定CpG位点精子甲基化显著降低。
- MEST、ZAC、KvDMR、PEG3和PEG10精子甲基化显著升高。
核心结论
- 某些印记基因的精子甲基化异常和IGF2-H19 DMR及IGF2多态性与RPL相关,可能参与RPL病因。
研究设计与样本
- 病例对照研究,纳入112对不明原因RPL夫妇和106对健康生育对照夫妇,研究期间为2015年9月至2018年5月。
主要发现
- RPL组精子整体5mC水平显著降低,LINE1启动子三个CpG位点甲基化显著降低。
- RPL组IGF2-H19 DMR和IG-DMR特定CpG位点精子DNA甲基化显著降低。
- RPL组MEST、ZAC、KvDMR、PEG3和PEG10等母源印记基因呈现高甲基化。
- IGF2-H19 DMR和IGF2多态性研究显示男性基因型频率存在显著差异。
临床怎么用
- 对不明原因RPL夫妇,可考虑评估男方精子印记基因甲基化及遗传多态性以辅助病因排查。
局限性
- 仅分析选定的候选印记基因甲基化水平,未进行全基因组甲基化检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the sperm DNA methylation status of imprinted genes in male partners from couples experiencing recurrent pregnancy loss (RPL)? SUMMARY ANSWER: Aberrations in sperm DNA methylation status of several imprinted genes, such as insulin like growth factor-2-H19 differentially methylated region (IGF2-H19 DMR), intergenic differentially methylated region (IG-DMR), mesoderm specific transcript (MEST), zinc finger protein which regulates apoptosis and cell cycle arrest (ZAC), DMR in intron 10 of KCNQ1 gene (KvDMR), paternally expressed gene 3 (PEG3) and paternally expressed gene 10 (PEG10), as well as decreased sperm global 5-methylcytosine (5mC) levels, are associated with RPL. WHAT IS KNOWN ALREADY: RPL is defined as loss of two or more pregnancies, affecting 1-2% of couples of reproductive age. Although there are several maternal and paternal aetiological factors contributing to RPL, nearly 50% of the cases remain idiopathic. Thus, there is a need to identify putative paternal factors that could be contributing towards pregnancy loss in cases of idiopathic RPL. STUDY DESIGN, SIZE, DURATION: In this case-control study, 112 couples undergoing RPL with no identifiable cause were recruited from September 2015 to May 2018. The control group comprised of 106 healthy proven fertile couples with no history of infertility or miscarriage. PARTICIPANTS/MATERIALS, SETTING, METHODS: In this study, we investigated the paternal genetic and epigenetic factors that could be associated with RPL. We studied DNA methylation, by pyrosequencing, of selected imprinted genes implicated in embryo development, such as IGF2-H19 DMR, IG-DMR, MEST, ZAC, KvDMR, PEG3, PEG10 and small nuclear ribonucleoprotein polypeptide N (SNRPN) in sperm of men whose partners present RPL. Global DNA methylation in sperm was evaluated by studying 5mC content and long interspersed nuclear element 1 (LINE1) promoter methylation. We also studied polymorphisms by pyrosequencing in the IGF2-H19 DMR as well in the IGF2 promoter in both groups. MAIN RESULTS AND THE ROLE OF CHANCE: In the RPL group, we found a significant decrease in the global sperm 5mC levels and significant decrease in DNA methylation at three CpG sites in LINE1 promoter. For IGF2-H19 DMR and IG-DMR, a significant decrease in sperm DNA methylation at specific CpG sites was observed in RPL group. For maternally imprinted genes like MEST, ZAC, KvDMR, PEG3 and PEG10 hypermethylation was noted. Polymorphism studies for IGF2-H19 DMR and IGF2 revealed significant differences in the genotypic frequencies in males. LIMITATIONS, REASONS FOR CAUTION: In this study, we analysed the methylation levels of selected candidate imprinted genes implicated in embryo development. Detection of methylation changes occurring at the genome-wide level may reveal further candidate genes having a better distinction between the control and study groups. WIDER IMPLICATIONS OF THE FINDINGS: Our study demonstrates that certain polymorphisms and aberrant sperm methylation status in imprinted genes are associated with RPL and could contribute to the aetiology of RPL. This study suggests that investigation of paternal genetic and epigenetic factors could be useful in identification of possible causes of idiopathic RPL. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by Department of Science and Technology-Science and Engineering Research Board (EMR/2014/000145) and National Institute for Research in Reproductive Health intramural funds (RA/872/01-2020). All authors declare no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Khambata K, Raut S, Deshpande S, et al. DNA methylation defects in spermatozoa of male partners from couples experiencing recurrent pregnancy loss. Hum Reprod. 2021. PMID: 33319906. doi:10.1093/humrep/deaa278
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。